Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1987
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Referenceopen allclose all

Reference Type:
other: NTP summary information
Title:
Unnamed
Year:
1987
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
GLP compliance:
yes
Remarks:
NTP study
Type of assay:
other: Chromosome aberration assay in mamalian cells

Test material

Constituent 1
Chemical structure
Reference substance name:
Castor oil
EC Number:
232-293-8
EC Name:
Castor oil
Cas Number:
8001-79-4
IUPAC Name:
Castor Oil
Specific details on test material used for the study:
Name as cited in study report: Castor oil

Method

Species / strain
Species / strain / cell type:
Chinese hamster Ovary (CHO)
Details on mammalian cell type (if applicable):
To assess induction of CA, cells were harvested in their first mitotic division after the initiation of chemical exposure.

MEDIA USED
McCoy's 5A medium supplemented with fetal calf serum, L-glutamine, and antibiotics; Colcemid
Metabolic activation:
with and without
Metabolic activation system:
Aroclor 1254 induced Sprague Dawley rat liver S9-mix
Test concentrations with justification for top dose:
1600, 3000 and 5000 µg/mL
Vehicle / solvent:
DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
DMSO 10 µg/mL
True negative controls:
no
Positive controls:
yes
Positive control substance:
cyclophosphamide
mitomycin C
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Without S9-mix: cells were incubated with study compound or solvent for 10 h at 37°C. Cells were then washed and fresh medium containing colcemid was added for an additional 3 h followed by harvest.
- With S9-mix: cells were incubated with study compound or solvent for 2 h at 37°C. Cells were then washed, medium without test compound was added, and incubation was continued for 10 h. Colcemid was added for the last 3 h of incubation before harvest.
- Expression time (cells in growth medium): 12 (without metabolic activation) or 13 hours (with metabolic activation).

SPINDLE INHIBITOR: colcemid

STAIN (for cytogenetic assays): The cells were harvested by mitotic shake-off, fixed, and stained with 6% Giemsa

NUMBER OF CELLS EVALUATED: 200 or 50 for the high dose positive control
Evaluation criteria:
For a single trial, a statistically significant (P<0.05) difference for one dose point and a significant trend (P<0.015) was considered weak evidence for a positive response; significant differences for two or more doses indicated the trial was positive. A strong trend (P < 0.003) with a single significant dose level was designated weak positive *, to indicate a high level of induced aberrations. A strongly positive trend (P < 0.003), in the absence of a statistically-significant increase at any one dose point, led to an equivocal call. Ultimately, the trial calls were based on a consideration of the statistical analyses as well as the biological information available to the reviewers. Trials that gave a weak positive or positive result were repeated. The overall result for the CA assay was based on an evaluation of the responses in all trials within an activation condition.
Statistics:
To arrive at a statistical call for a trial, analyses were conducted to assess the presence of a dose-response (trend test) and the significance of the individual dose points compared to the vehicle control

Results and discussion

Test results
Key result
Species / strain:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid

Applicant's summary and conclusion